Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Abacavir as initial therapy and as a once-daily drug.
Sax
P E
PE
D018791:CD4 Lymphocyte Count; D015224:Dideoxynucleosides / Q000627:therapeutic use*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D019562:Viral Load; D000099227:Abacavir
D015224:Dideoxynucleosides; D010919:Placebos; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir